Results for:(64 found)
Oct 31, 2012 12:10PM on Top StocksBy TheStreet Staff

The second-generation HIV drug is being developed to counteract expiring patents.

Oct 31, 2012 10:38AM on Top StocksBy InvestorPlace

The revenue in question seems too small to make a difference.

Sep 19, 2012 11:01AM on Top StocksBy MSN Money Partner

GlaxoSmithKline is downgraded to 'underperform,' while AstraZeneca is upgraded to 'neutral.'

Aug 28, 2012 2:45PM on Top StocksBy Minyanville.com

The US approval of Stribild is a big plus for the company's AIDS treatment franchise.

Aug 28, 2012 11:13AM on Top StocksBy MSN Money Partner

Eli Lilly is upgraded to 'overweight,' and GlaxoSmithKline is downgraded to 'neutral.'

Aug 22, 2012 11:12AM on Top StocksBy MSN Money Partner

Roche is upgraded to 'overweight,' while GlaxoSmithKline is downgraded to 'underweight.'

Aug 13, 2012 11:14AM on Top StocksBy MSN Money Partner

Sprint is upgraded to 'buy,' while Coca-Cola is downgraded to 'neutral.'

Jul 27, 2012 10:22AM on Top StocksBy Minyanville.com

The heart pill could be a blockbuster product.

Tags: AMRNGSK

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

SMART SPENDING

What does your credit report say about you?

A WisePiggy.com poll found that many Americans, especially older ones, do little or nothing to protect their credit scores and reports. See why you should check your credit history.

More